Antibodies that potently neutralize highly diverse HIV-1 variants offer great potential for therapy and prevention. Passive administration of HIV-specific neutralizing antibodies genetically modified to have a long serum half-life has now been shown to confer long-lasting protection from infection in the rhesus macaque model.
This is a preview of subscription content, log in via an institution to check access.
References
Gautam, R. et al. Nature 533, 105–109 (2016).
Gautam, R. et al. Nat. Med. https://doi.org/10.1038/s41591-018-0001-2 (2018).
Ko, S. Y. et al. Nature 514, 642–645 (2014).
Ledgerwood, J. E. et al. Clin. Exp. Immunol. 182, 289–301 (2015).
Caskey, M. et al. Nature 522, 487–491 (2015).
Caskey, M. et al. Nat. Med. 23, 185–191 (2017).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Zanoni, M., Palesch, D. & Silvestri, G. Longing for HIV protection. Nat Microbiol 3, 648–649 (2018). https://doi.org/10.1038/s41564-018-0169-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41564-018-0169-8
- Springer Nature Limited